A targetable type III immune response with increase of IL-17A expressing CD4<sup>+</sup> T cells is associated with immunotherapy-induced toxicity in melanoma.
- DOI
- 10.1038/s43018-024-00810-4
- Published
- 2024-08-29
- Container
- Nat Cancer
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/s43018-024-00810-4,
title = {A targetable type III immune response with increase of IL-17A expressing CD4\<sup\>+\</sup\> T cells is associated with immunotherapy-induced toxicity in melanoma.},
author = {Dimitriou F and Cheng PF and Saltari A and Schaper-Gerhardt K and Staeger R and Haunerdinger V and Sella F and Tastanova A and Urban C and Dettwiler S and Mihic-Probst D and Matter CM and Michielin O and Gutzmer R and Long GV and Becher B and Levesque MP and Dummer R.},
year = {2024},
journal = {Nat Cancer},
doi = {10.1038/s43018-024-00810-4},
url = {https://doi.org/10.1038/s43018-024-00810-4}
}RIS
TY - JOUR TI - A targetable type III immune response with increase of IL-17A expressing CD4<sup>+</sup> T cells is associated with immunotherapy-induced toxicity in melanoma. AU - Dimitriou F AU - Cheng PF AU - Saltari A AU - Schaper-Gerhardt K AU - Staeger R AU - Haunerdinger V AU - Sella F AU - Tastanova A AU - Urban C AU - Dettwiler S AU - Mihic-Probst D AU - Matter CM AU - Michielin O AU - Gutzmer R AU - Long GV AU - Becher B AU - Levesque MP AU - Dummer R. PY - 2024 JO - Nat Cancer DO - 10.1038/s43018-024-00810-4 UR - https://doi.org/10.1038/s43018-024-00810-4 ER -
APA
F, D., PF, C., A, S., K, S., R, S., V, H., F, S., A, T., C, U., S, D., D, M., CM, M., O, M., R, G., GV, L., B, B., MP, L., & R., D. (2024). A targetable type III immune response with increase of IL-17A expressing CD4<sup>+</sup> T cells is associated with immunotherapy-induced toxicity in melanoma.. Nat Cancer. https://doi.org/10.1038/s43018-024-00810-4
Source records
- europe-pmc · retrieved 2026-09-26T20:49:29.521Z